You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 288 No. 15, October 16, 2002 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA
 Topic Collections
 •Revascularization
 •Cardiovascular System
 •Surgery
 •Surgical Interventions
 •Cardiovascular/ Cardiothoracic Surgery
 •Cardiovascular Disease/ Myocardial Infarction
 •Cardiovascular Intervention
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Invasive vs Conservative Management of Acute Coronary Syndromes

Do the Data Support the Guidelines?

David J. Cohen, MD,MSc

JAMA. 2002;288:1905-1907.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Acute coronary syndromes (ACSs) account for approximately 1.4 million hospitalizations each year in the United States alone, and more than 2 million worldwide.1 Until recently, however, there was no consistent guidance as to how such patients should be optimally managed during the hospital phase. Some clinicians favored an early invasive strategy, with cardiac catheterization during the first 24 to 48 hours of presentation. Others favored a more conservative strategy with initial medical stabilization followed by cardiac catheterization only if the patient demonstrated high-risk features (such as recurrent myocardial ischemia or congestive heart failure) or significant myocardial ischemia on noninvasive testing. Although the invasive strategy offers the ability to identify patients with high-risk coronary anatomy quickly and definitively, several clinical trials suggested that these potential benefits were offset by the early risks of revascularization procedures in these high-risk subgroups.2-3

Recently, however, 2 large-scale randomized clinical trials have . . . [Full Text of this Article]

Author Affiliations: Harvard Clinical Research Institute and the Cardiovascular Division, Beth Israel Deaconess Medical Center, Boston, Mass.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLE

Cost and Cost-effectiveness of an Early Invasive vs Conservative Strategy for the Treatment of Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction
Elizabeth M. Mahoney, Claudine T. Jurkovitz, Haitao Chu, Edmund R. Becker, Steven Culler, Andrzej S. Kosinski, Debbie H. Robertson, Charles Alexander, Soma Nag, John R. Cook, Laura A. Demopoulos, Peter M. DiBattiste, Christopher P. Cannon, William S. Weintraub, and for the TACTICS-TIMI 18 Investigators
JAMA. 2002;288(15):1851-1858.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Application of Current Guidelines to the Management of Unstable Angina and Non-ST-Elevation Myocardial Infarction
Braunwald
Circulation 2003;108:III-28-37.
ABSTRACT | FULL TEXT  

Invasive Strategy Cost-Effective for UA/NSTEMI Patients
Journal Watch Cardiology 2002;2002:7-7.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.